Low birth weight in Papua New Guinea is a killer. Help us research what is causing low birth weight in PNG so that we can stop it.
Clinical management, consisting of regular monitoring, and for a minority of people pharmaceutical treatment, reduces hepatitis B disease progression.
Of all people with hepatitis B in Australia, only 13 per cent are clinically managed and of the 5 per cent that do receive pharmaceutical treatment, 20 per cent do not regularly take their medication.
A major gap in the public health response to hepatitis B is to identify the reasons for the reported ‘non-compliance’ of people with hepatitis B to the current model of care or identifying the elements of an effective clinical guideline and future model of care.
2020 – 2021